Comparative safety of tetracycline, minocycline, and doxycycline

Archives of Dermatology

Volumn 133, Issue 10, 1997, Pages 1224-1230

  Shapiro, Lori E ^a   Knowles, Sandra R ^a   Shear, Neil H ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; MINOCYCLINE; TETRACYCLINE;

ARTICLE; CLINICAL ARTICLE; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG SAFETY; FEMALE; HUMAN; LUPUS VULGARIS; MALE; PRIORITY JOURNAL; SERUM SICKNESS;

EID: 0030824857     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.10.1224     Document Type: Article

References (77)

1. Knowles S, Shapiro L, Shear N. Serious adverse reactions induced by minocycline: report of 13 patients and review of the literature. Arch Dermatol. 1996; 132:934-939.
2. Gough A, Chapman S, Wagstaff K, Emery P, Elias E. Minocycline-induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ. 1996; 312:369-372.
3. Malcolm A, Heap T, Eckstein R, Lunzer M. Minocycline-induced liver injury. Am J Gastroenterol. 1996;91:1641-1643.
4. Harel L, Amir J, Livni E, Straussberg R, Varsano I. Serum-sickness-like reaction associated with minocycline therapy in adolescents. Ann Pharmacother. 1996; 30:481-483.
5. Golstein P, Deviere J, Cremer M. Acute hepatitis and drug-related lupus induced by minocycline treatment. Am J Gastroenterol. 1997;92:143-146.
6. Sitbon O, Bidel N, Dusopt C, et al. Minocycline pneumonitis and eosinophilia: a report on eight patients. Arch Intern Med. 1994;154:1633-1640.
7. Davies M, Kersey P. Acute hepatitis and exfoliative dermatitis associated with minocycline. BMJ. 1989;298:1523-1524.
8. Kaufmann D, Pichler W, Beer J. Severe episode of high fever with rash, lymphadenopathy, neutropenia, and eosinophilia after minocycline therapy for acne. Arch Intern Med. 1994;154:1983-1984.
9. Min DI, Burke PA, Lewis WD, Jenkins RL. Acute hepatic failure associated with oral minocycline: a case report. Pharmacotherapy. 1992;12:68-71.
10. Wilkinson S, Stewart W, Spiers E, Pears J. Protracted systemic illness and interstitial nephritis due to minocycline. Postgrad Med J. 1989;65:53-56.
11. Parneix-Spake A, Bastuji-Garin S, Lobut J, et al. Minocycline as a possible cause of severe and protracted hypersensitivity drug reaction. Arch Dermatol. 1995; 131:490-491.
12. Inoue C, Kondo Y, Suwabe N, Igarashi Y, Tada K. Minocycline-related lupus in childhood. Eur J Pediatr. 1994;153:540.
13. Matsuura T, Shimizu Y, Fujimoto H, Miyazaki T, Kano S. Minocycline-related lupus. Lancet. 1993;340:1553.
14. Byrne PAC, Williams BD, Pritchard MH. Minocycline-related lupus. Br J Rheumatol. 1994;33:674-676.
15. Quilty B, McHugh N. Lupus-like syndrome associated with the use of minocycline. Br J Rheumatol. 1994;33:1197-1198.
16. Bulgen D. Minocycline-related lupus. Br J Rheumatol. 1995;34:398.
17. Gordon P, White M, Herriot R, Martin J, Reid D. Minocycline-associated lupus erythematosus. Br J Dermatol. 1995;132:120-121.
18. Toyoshima M, Sato A, Hayakawa H, Taniguchi M, Imokawa S, Chida K. A clinical study of minocycline-induced pneumonitis. Intern Med. 1996;35:176-179.
19. Otero M, Goodpasture H. Pulmonary infiltrates and eosinophilia from minocycline. JAMA. 1983;250:2602.
20. Guillon J-M, Joly P. Autran B, et al. Minocycline-induced cell-mediated hypersensitivity pneumonitis. Ann Intern Med. 1992;117:476-481.
21. Kloppenburg M, Dijkmans B, Breedveld F. Hypersensitivity pneumonitis during minocycline treatment. Neth J Med. 1994;44:210-213.
22. Bando T, Fujimura M, Noda Y, Hirose J-I, Ohta G, Matsuda T. Minocycline-induced pneumonitis with bilateral hilar lymphadenophathy and pleural effusion. Intern Med. 1994;33:177-179.
23. Bridges A. Minocycline-induced pneumonia. Ann Intern Med. 1993;118:749-750.
24. Burette A, Finet C, Prigogine T, De Roy G, Deltenre M. Acute hepatic injury associated with minocycline. Arch Intern Med. 1984;144:1491-1492.
25. Gorard D. Late-onset drug fever ssociated with minocycline. Postgrad Med J. 1990;66:404-406.
26. Gaffney K, Merry P. Antineutrophil cytoplasmic antibody-positive polyarthritis associated with minocycline therapy. Br J Rheumatol. 1996;35:1327.
27. Elkayam O, Yaron M, Caspi D. Minocycline-induced arthritis associated with fever, livedo reticularis, and pANCA. Ann Rheum Dis. 1996;55:769-771.
28. Walker R, Thomson N, Dowling J, Ogg C. Minocycline-induced acute interstitial nephritis. BMJ. 1979;1:524.
29. Boudreaux J, Hayes D, Mizrahi S, Hussey J, Regenstein F, Balart L. Fulminant hepatic failure, hepatorenal syndrome, necrotizing pancreatitis after minocycline hepatotoxicity. Transplant Proc. 1993;25:1873.
30. Shoji A, Someda Y, Hamada T. Stevens-Johnson syndrome due to minocycline therapy. Arch Dermatol. 1987;123:18-20.
31. Masson C, Chevallier A, Pascaretti C, Legrand E, Bregeon C, Audran M. Minocycline related lupus. J Rheumatol. 1996;23:2160-2161.
32. Sigmann P. Minocycline-induced pneumonia. Ann Intern Med. 1993;118:750.
33. Yokoyama A, Mizushima Y, Suzuki H, Arai N, Kitagawa M, Yana S. Acute eosinophilic pneumonia induced by minocycline: prominent Kerley B lines as a feature of positive rechallenge test. Jpn J Med. 1990;29:195-198.
34. Puyana J, Urena V, Quirce S, Fernandez-Rivas M, Cuevas M, Fraj J. Serum sickness-like syndrome associated with minocycline therapy. Allergy. 1990;45:313-315.
35. Burge S, Dawber R. Stevens-Johnson syndrome and toxic epidermal necrolysis in a patient with systemic lupus erythematosus. J Am Acad Dermatol. 1985;13: 665-666.
36. Elmore M, Rogge J. Tetracycline-induced pancreatitis. Gastroenterology. 1981; 81:1134-1136.
37. Fenoglio J, McAllister H, Mullick F. Drug-related myocarditis: hypersensitivity myocarditis. Hum Pathol. 1981;12:900-907.
38. Ho D, Tashkin D, Bein M, Sharma O. Pulmonary infiltrates with eosinophilia associated with tetracycline. Chest. 1979;76:33-36.
39. Mazza J, Kryda M. Tetracycline-induced hemolytic anemia. J Am Acad Dermatol. 1980;2:506-508.
40. Simpson M, Pryzbylik J, Innis B, Denham M. Hemolytic anemia after tetracycline therapy. N Engl J Med. 1985;312:840-842.
41. Torosis J, Vender R. Tetracycline-induced pancreatitis. J Clin Gastroenterol. 1987; 9:580-581.
42. Pan C, Quintela A. Doxycycline-induced parotitis. Postgrad Med J. 1991;67:313-314.
43. Lewis-Jones M, Evans S, Thompson C. Erythema multiforme occurring in association with lupus erythematosus during therapy with doxycycline. Clin Exp Dermatol. 1988;13:245-247.
44. Albengres E, Guillaume J, Chevais M, Riant P, Touraine R, Tillement J. Recurrent erythema multiforme following successive treatments with tetracyclines: apropos of a case. Therapie. 1983;38:577-579.
45. Curley R, Verbov J. Stevens-Johnson syndrome due to tetracyclines: a case report (doxycycline) and review of the literature. Clin Exp Dermatol. 1987;12:124-125.
46. Wolkenstein P, Revuz J. Drug-induced severe skin reactions: incidence, management and prevention. Drug Safety. 1995;13:56-68.
47. Chatham W, Ross D. Leukemoid blood reaction to tetracycline. South Med J. 1983;76:1195-1196.
48. Nicolau D, Mengedoht D, Kline J. Tetracycline-induced pancreatitis. Am J Gastroenterol. 1994;86:1669-1671.
49. Schultz J, Adamson J, Workman W, Norman T. Fatal liver disease after intravenous administration of tetracycline in high dosage. N Engl J Med. 1963;269: 999-1004.
50. Schenker S. Tetracycline hepatotoxicity. Mater Med Pol. 1976;2:173-176.
51. Meihoff W, Pasquale D, Jacoby W. Tetracycline-induced hepatic coma, with recovery: report of a case. Obstet Gynecol. 1967;29:260-265.
52. Dowling H, Lepper M. Hepatic reactions to tetracycline. JAMA. 1964;188:307-309.
53. Combes B, Whalley P, Adams R. Tetracycline and the liver. Prog Liver Dis. 1972; 4:589-596.
54. Naranjo C, Busto U, Sellers E, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
55. Reboli A, Del Bene V. Oral antibiotic therapy of dermatologic conditions. Dermatol Clin. 1988;6:497-520.
56. Dry E. The tetracyclines. Med Clin North Am. 1970;54:1173-1186.
57. Allen J. Minocycline. Ann Intern Med. 1976;85:482-487.
58. Taurog A, Dorris M, Doerge D. Minocycline and the thyroid: antithyroid effects of the drug, and the role of thyroid peroxidase in minocycline-induced black pigmentation of the gland. Thyroid. 1996;6:211-219.
59. Shear N, Spielberg S. Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. J Clin Invest. 1988;82:1826-1832.
60. Kearns G, Wheeler J, Childress S, Letzig L. Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility. J Pediatr. 1994; 125:805-811.
61. Domz C, McNamara D, Holzapfel H. Tetracycline provocation in lupus erythematosus. Ann Intern Med. 1959;50:1217-1226.
62. Uetrecht J. The role of leukocyte-generated metabolites in the pathogenesis of idiosyncratic drug reactions. Crit Rev Toxicol. 1992;20:299-366.
63. Hess E. Drug-related lupus. N Engl J Med. 1988;318:1460-1462.
64. George D, Crawford D. Antibacterial-induced hepatotoxicity: incidence, prevention and management. Drug Safety. 1996;15:80-85.
65. Derby L, Jick H, Henry D, Dean A. Cholestatic hepatitis associated with flucloxacillin. Med J Aust. 1993;158:596-600.
66. Carson J, Strom B, Duff A, et al. Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines. Ann Intern Med. 1993;119:576-583.
67. Goulden V, Glass D, Cunliffe W. Safety of long-term high-dose minocycline in the treatment of acne. Br J Dermatol. 1996;134:693-695.
68. Hanley J, Lippman-Hand A. If nothing goes wrong, is everything all right? interpreting zero numerators. JAMA. 1983;249:1743-1745.
69. Cunliffe W. Doctors should not change the way they prescribe for acne. BMJ. 1996;312:1101.
70. Singer S, Piazza-Hepp T, Girardi L, Moledina N. Lupuslike reaction associated with minocycline. JAMA. 1997;277:295-296.
71. Kale S. Drug-induced systemic lupus erythematosus: differentiating it from the real thing. Postgrad Med. 1985;77:231-242.
72. McDonald E, Marino C. Drug-induced lupus. Hospital Pract. 1993:14.
73. Gupta A, Eggo M, Uetrecht J, Shear N. Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides. Clin Pharmacol Ther. 1992;51:56-67.
74. Hubbell C, Hobbs E, Rist T, et al. Efficacy of minocycline compared with tetracycline in treatment of acne vulgaris. Arch Dermatol. 1982;118:989-992.
75. Driscoll M, Rothe M, Abrahamian L, Grant-Kels J. Long-term oral antibiotics for acne: is laboratory monitoring necessary? J Am Acad Dermatol. 1993;28:595-602.
76. Ferner R, Moss C. Minocycline for acne. BMJ. 1996;312:138.
77. Lehrnert L, Cooke J, Enck R. Tetracycline-induced aplastic anemia. South Med J. 1979;72:358-361.